(f) Image analysis of amyloid load ... (d) Aß(1-40) in brain microvessels in Tg2576 mice and controls. (e) CBF in 9-month-old Tg2576 mice () and controls (). BP, blood pressure.
The study found increased permeability in the blood-brain barrier of APOE4 carriers, including those without cognitive symptoms or amyloid beta buildup. The blood-brain barrier is a critical ...
Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...
Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 million upfront for global rights to two preclinical antibodies.